Body mass index, waist circumference, and chronic disease risk factors in australian adolescents by Denney-Wilson, E et al.
ARTICLE
Body Mass Index, Waist Circumference,
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Objective: To determine the association between mea-
sures of adiposity (body mass index and waist circum-
ference) and risk factors for heart disease, type 2 diabe-
tes, fatty liver disease, and the clustering of risk factors
in middle adolescence.
Design: Cross-sectional study.
Setting: Secondary schools in Sydney.
Participants: Grade 10 students (N=496; 58.4% boys;
mean [SD] age, 15.4 [0.4] years).
Main Exposures: Height, weight, waist circumfer-
ence, blood pressure, and fasting blood samples.
Outcome Measures: Participants were categorized as
overweight or obese using the International Obesity Task
Force cut points and the UK waist circumference cut
points. Blood was analyzed for high- and low-density li-
poprotein cholesterol, triglycerides, insulin, glucose, ala-
nine aminotransferase, -glutamyltransferase, and high-
sensitivity C-reactive protein levels, and the results were
categorized as normal or abnormal according to pub-
lished guidelines where possible. Associations between
overweight and obesity and risk factors were explored
using logistic regression. Clustering of risk factors within
individuals was also explored.
Results: Insulin (P .001), alanine aminotransferase
(P .001), -glutamyltransferase (P= .005), high-
density lipoprotein cholesterol (P .001), high-
sensitivity C-reactive protein (P .001), and blood pres-
sure (P .001) were significantly associated with
overweight and obesity in adolescent boys. In adolescent
girls, insulin, high-density lipoprotein cholesterol
(P .001), and high-sensitivity C-reactive protein
(P .001) were significantly associated with overweight
and obesity. Obese adolescent boys and girls were signifi-
cantly more likely to have 2 or more risk factors (boys:
73.5% vs 7.6%; girls: 44.4% vs 5.4%; P .001 for both)
than nonoverweight adolescents.
Conclusions: Overweight and obese adolescents, espe-
cially boys, are at substantial risk for chronic condi-
tions. Waist circumference is not a better predictor of
metabolic risk factors than is body mass index.
Arch Pediatr Adolesc Med. 2008;162(6):566-573
T HE PREVALENCE OF OVER-weight and obesity in ado-lescents is increasing world-wide.1 Several studies2-4 haveshown that obese children
and adolescents have an increased preva-
lence of metabolic risk factors for cardio-
vascular disease, type 2 diabetes, and, more
recently, fatty liver disease. Although mor-
bidity could be expected to increase in par-
allel with the prevalence of obesity, little is
known about chronic disease risk factors
in the general adolescent population. Most
studies of comorbidities either have been
conducted in clinic-based groups of se-
verely obese adolescents5-7 or have not stud-
ied the full range of metabolic complica-
tions.6,8,9 Adults categorized as “overweight”
(or who exceed a waist circumference cut
point) are cautioned that they may be at in-
creased risk for cardiovascular disease and
type 2 diabetes10; however, it is unclear what
level of excess adiposity should raise con-
cern in adolescents. Identifying adoles-
cents at risk for long-term morbidity and
offering early intervention may improve
long-term outcomes.
The aim of this research is to charac-
terize the associations between body mass
index (BMI) (calculated as weight in ki-
lograms divided by height in meters
squared) and waist circumference and risk
factors for the major complications of obe-
sity, including diabetes, cardiovascular dis-
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ease, and nonalcoholic fatty liver disease, in a represen-
tative sample of adolescents. Because multiple risk factors
in an individual may amplify risk of morbidity, a sec-
ondary aim of this study is to examine the clustering of
risk factors within adolescents.
METHODS
DESIGN
The biomarker study was a substudy of the New South Wales
Schools Physical Activity and Nutrition Survey (SPANS 2004).
The methods used in the SPANS 2004 have been described in
detail elsewhere11 and are only briefly explained herein. The
SPANS 2004 was a representative population survey of stu-
dents attending kindergarten and grades 2, 4, 6, 8, and 10 in
primary and secondary schools in New South Wales, the most
highly populated state in Australia. Data were collected be-
tween February 26, 2004, and May 11, 2004. The self-report
questionnaire was administered only to students in grades 6,
8, and 10. The study was approved by the University of Syd-
ney human research and ethics committee, the New South Wales
Department of Education and Training, and the New South
Wales Catholic Education Commission (all in Sydney).
SAMPLE SELECTION AND RECRUITMENT
A total of 45 primary and 48 secondary schools were ran-
domly selected so that the number of schools selected in each
education sector (government, Catholic, and independent) was
proportional to the number of students enrolled in that sec-
tor. Special schools, schools with enrollments of fewer than 180
students, and schools in geographically remote regions were
excluded from the sampling frame. Despite these exclusions,
81.7% and 96.5% of the primary and secondary school popu-
lations, respectively, were included in the sampling frame. The
likelihood of a school being selected was proportional to the
size of the student enrollment. Within each school, 1 class was
chosen at random from each of the grades being surveyed, ex-
cept for grade 10, in which 2 classes were randomly selected.
Informed consent by the selected students and their care-
givers was a requirement for participation.
The biomarker substudy involved blood sample collection
from 500 grade 10 students (mean age, 15.4 years) attending
28 schools in the Sydney metropolitan area. The differences in
cultural background and enrollment in each education sector
between the sample described in this article and the popula-
tion of New South Wales were tested using the 1-way Rao and
Scott 2 test (an adjustment to the standard 2 test that allows
for a stratified, cluster-sampled, survey design). The propor-
tion of students from English-speaking backgrounds was simi-
lar to the population as a whole but was smaller for students
from Middle Eastern and European backgrounds and higher
for students from Asian backgrounds. The difference in the dis-
tributions was statistically significant; however, the number of
students from European (n=13), Middle Eastern (n=13), and
Asian (n=74) backgrounds was relatively small. The distribu-
tion across education sectors was not significantly different from
that across the population as a whole. The prevalence of over-
weight and obesity was not significantly different from that of
the study population as a whole. It is reasonable, therefore, to
conclude that the biomarker prevalence estimates are repre-
sentative of the population values.
All the students were asked to report their sex, date of birth,
language spoken most at home, school grade, and suburb and
postal code of residence.
BLOOD SAMPLES, BLOOD PRESSURE,
AND PUBERTAL STATUS
After an overnight fast, approximately 20 mL of venous blood
was collected and analyzed for concentrations of high-density
lipoprotein (HDL) and low-density lipoprotein (LDL) choles-
terol, triglycerides, glucose, insulin, high-sensitivity C-
reactive protein (hs-CRP), and the liver enzymes alanine ami-
notransferase (ALT) and -glutamyltransferase (GGT). After
the student had been sitting quietly for at least 10 minutes, blood
pressure was measured using a mercury sphygmomanometer
on the right arm with an appropriately sized cuff that covered
at least two-thirds of the upper arm. The first and fifth Korot-
koff sounds were recorded as systolic and diastolic blood pres-
sure, respectively. Adolescents were asked to self-report their
stage of pubertal development using the descriptions pro-
vided by Tanner.12 Male participants were asked to report their
stage of pubic hair and genital development, and female par-
ticipants were asked if they had begun menstruating and to de-
scribe their stage of breast development. The instructions for
completing the form were given to each student individually,
in private, by 1 of us (E.D.-W.).
BIOCHEMICAL ANALYSIS
The specimens were transported to a National Association of Test-
ing Authorities–accredited pathology laboratory for analysis. Glu-
cose, total cholesterol, HDL and LDL cholesterol, triglyceride,
ALT, and GGT levels were measured using standard tech-
niques. The plasma insulin concentration was measured using
the Bayer Advia Centaur Immunoassay with Bayer Centaur Re-
agent (Bayer Healthcare, Leverkusen, Germany). The hs-CRP con-
centration was measured at the Royal Prince Alfred Lipid Labo-
ratory using an automated nephelometer (Immage; Beckman
Coulter, Sydney) with the use of an ultrasensitive assay. The co-
efficient of variation was 7.4% for interassay variation based on
that achieved with a commercial control at a mean level of 0.89
mg/L performed on 15 different occasions.
ANTHROPOMETRY
Height was measured to the nearest millimeter using portable
height scales (PE87; Mentone Educational Centre, Moorabbin,
Australia) and the stretch stature method, with shoes removed.
Weight was measured to the nearest 0.1 kg using portable bath-
room scales (Tanita 1597; Mentone Educational Centre), with
students’ shoes and heavy clothing removed. Because the mea-
surements were taken in summer, the standard school uniform
was light. Height and weight measurements were used to calcu-
late BMI. Each student was categorized as nonoverweight, over-
weight, or obese using the International Obesity Task Force defi-
nition based on their decimal age.13 Nonextensible steel tapes
were used to measure waist circumference (in centimeters) at
the narrowest point between the lower costal border and the iliac
crest. If there was no obvious narrowing at the waist, the mea-
surement was taken midway between the costal border and the
iliac crest. Participants were categorized as nonoverweight, over-
weight (91st percentile), or obese (98th percentile) using the UK
Child Growth Foundation Charts 1997.14
DATA ANALYSIS
Data were analyzed using SAS version 9.1 (SAS Institute Inc,
Cary, North Carolina). Analysis of the biomarkers was per-
formed after categorizing each as high (or low in the case of
HDL cholesterol) or normal for adolescent participants. Where
possible, evidence-based reference standards were used; how-
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ever, reference standards are not available for all of the stud-
ied markers, and the decisions regarding choice of cut points
are outlined in the “Biomarker Cut Points” subsection. The num-
ber and proportion of students with abnormal biomarker val-
ues were tabulated by adiposity category separately by sex. For
each biomarker, univariate associations with both of the an-
thropometric measures were assessed using odds ratios (ORs),
95% confidence intervals (CIs), and results from hypothesis tests.
Associations were assessed using the SURVEYLOGISTIC pro-
cedure in SAS version 9.1, which adjusts for the complex de-
sign of the survey.
Multiple logistic regression models were constructed to as-
sess the joint contribution of biomarkers on adiposity using a
backward elimination process, again separately by sex. The over-
weight and obese categories were combined to avoid the prob-
lem of small numbers of children for some biomarkers. Bio-
markers that showed some univariate association with adiposity
(as assessed by P .25) were included in the modeling proce-
dure. The final models were confirmed by using a forward ad-
dition procedure. Colinearity was checked for by examining
changes in model estimates and standard errors. The number
of risk factors was examined and calculated from the follow-
ing 8 biomarkers: elevated insulin, elevated glucose, elevated
ALT, elevated GGT, low HDL cholesterol, elevated LDL cho-
lesterol, elevated hs-CRP, and high blood pressure values.
BIOMARKER CUT POINTS
Insulin and Glucose
Reference standards for determining “elevated” insulin levels
are not available for adolescents; however, several authors15-18
have used the 75th percentile in their study populations as an
arbitrary cut point. The present data have also been analyzed
in terms of quartiles, with levels at the 75th percentile or greater
(ie, 90.28 µIU/mL in adolescent boys and 97.23 µIU/mL in ado-
lescent girls [to convert to picomoles per liter, multiply by
6.945]) considered elevated. The levels that correspond to the
75th percentile in this study population are similar to those re-
ported in the Bogalusa Heart Study, the Cardiovascular Risk
in Young Finns Study, and the Quebec Family Study in people
of similar age.17 Glucose concentrations greater than 110 mg/dL
(to convert to millimoles per liter, multiply by 0.0555) were
defined as high based on the American Academy of Pediatrics’
National Cholesterol Education Program definition.19
ALT and GGT
No reference standards exist for categorizing ALT or GGT in
adolescents. In the absence of a standard definition, an ALT
cut point of 30 U/L (to convert to microkatals per liter, mul-
tiply by 0.0167) was adopted, although several authors20,21 sug-
gest that this may underestimate the true prevalence of liver
injury because the “reference” population probably included
people with fatty liver disease. A GGT concentration of 30 U/L
or greater (to convert to microkatals per liter, multiply by 0.0167)
was considered elevated for adolescents, in accordance with Ro-
chling.22 Similar caution must be observed as with the inter-
pretation of ALT because the reference population on whom
this cut point is based would not be free of people with liver
abnormalities.
Lipids
The HDL and LDL cholesterol cut points were based on the
American Academy of Pediatrics’ Cholesterol in Childhood
guidelines.23 Thus, an HDL cholesterol concentration less than
40 mg/dL (to convert to millimoles per liter, multiply by 0.0259)
is considered “at risk”23 and, for consistency with the rest of
the analysis, is referred to as “low.” The guidelines recom-
mend an LDL cholesterol concentration less than 110 mg/dL
in adolescents from families with hypercholesterolemia or pre-
mature cardiovascular disease and that the cut point for a “high”
LDL cholesterol level is 130 mg/dL.19 We had no access to par-
ticipants’ family history, but adopting a conservative view, the
present analysis categorizes an LDL cholesterol concentration
greater than 131 mg/dL as high. Triglyceride concentrations
greater than 199 mg/dL (to convert to millimoles per liter, mul-
tiply by 0.0113) were categorized as high using the American
Heart Association recommendations.24
High-Sensitivity C-reactive Protein
The American Heart Association and the US Centers for Dis-
ease Control and Prevention have stated that in population stud-
ies of risk of cardiovascular disease in adults, an hs-CRP con-
centration of 1.0 mg/L or less (to convert to nanomoles per liter,
multiply by 9.524) should be considered low risk, a concen-
tration greater than 1.0 mg/L but 3.0 mg/L or less should be
considered moderate risk, and concentrations greater than 3.0
mg/L should be considered high risk.17 In the present analysis,
an hs-CRP concentration greater than 3.0 mg/L was consid-
ered high. The hs-CRP level is a nonspecific marker of inflam-
mation, and levels greater than 10.0 mg/L may reflect an im-
mediate-phase response to infectious disease.24 Consequently,
6 participants (5 boys and 1 girl) were excluded from further
hs-CRP analysis.
Blood Pressure
Blood pressure was interpreted using the percentile charts pro-
vided in the third revision of the US National Heart, Lung, and
Blood Institute’s Task Force Report on High Blood Pressure in
Children and Adolescents25 and the height charts developed by
the US Centers for Disease Control and Prevention.26 Partici-
pants with a systolic or diastolic blood pressure greater than
the 90th percentile, adjusted for height, age, and sex, were cat-
egorized as having high blood pressure.
RESULTS
ANTHROPOMETRY
Of the 500 blood samples collected, 2 were excluded ow-
ing to the presence of preexisting type 1 diabetes and 2
were missing anthropometric data, leaving 496 samples
available for analysis (58.4% boys). Table 1 summa-
rizes the characteristics of the sample. Based on BMI, the
combined prevalence of overweight and obesity in ado-
lescent boys was 27.6%, and 20.0% of adolescent boys
were overweight or obese based on waist circumference
cut points. The combined prevalences in adolescent girls
were 19.4% based on BMI and 18.0% based on waist cir-
cumference. Both BMI and waist circumference were
highly correlated in adolescent boys and girls (R=0.89
and P .001 for both). The BMI z scores were calcu-
lated based on the Centers for Disease Control and Pre-
vention 2000 growth reference charts.27,28 The mean (SD)
BMI z score was 0.25 (1.03). Waist circumference z scores
were calculated based on an Australian population, and
the mean (SD) was −0.38 (1.35).27
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BIOMARKERS
Cardiovascular risk factors were relatively common, with
high blood pressure being the most prevalent risk factor
in adolescent boys (22.1%) and girls (10.8%). The me-
dian and interquartile range of each of the biomarkers
are given in Table 2. Low HDL cholesterol levels and
elevated hs-CRP levels were also relatively common, with
10.7% of adolescent boys and 3.9% of adolescent girls
having low HDL cholesterol levels and 7.5% of adoles-
cent boys and 8.6% of adolescent girls having high hs-
CRP levels. The prevalence of abnormal values of some
biomarkers was low, in particular, glucose (0.7% of ado-
lescent boys and no adolescent girls), LDL cholesterol
(4.5% of adolescent boys and 6.3% of adolescent girls),
triglycerides (1.0% of adolescent boys and 0.5% of ado-
lescent girls), and GGT (3.5% of adolescent boys and 2.4%
of adolescent girls). Most adolescent boys and girls in this
study were in the latter stages of puberty, and mean in-
sulin values did not vary consistently across Tanner stages
within BMI categories.
ASSOCIATIONS BETWEEN OVERWEIGHT
AND CHRONIC DISEASE RISK FACTORS
Adolescent boys were more likely to have risk factors than
adolescent girls, and in all cases the association between
the risk factor and adiposity was stronger in adolescent
boys than in adolescent girls. Table 3 and Table 4 pro-
vide the associations between overweight and obesity, mea-
sured using BMI and waist circumference, and the bio-
markers in adolescent boys and girls. The ORs, 95% CIs,
and comparisons across weight categories are also given.
Adolescent Boys
Obesity (defined by either BMI or waist circumference)
was significantly associated with abnormal values of in-
sulin, ALT, GGT, HDL cholesterol, hs-CRP, and blood pres-
sure. Waist circumference provided a slightly stronger as-
sociation with high GGT and low HDL cholesterol levels,
but with reduced precision of the estimate. The results of
multivariable analysis are given in Table 5. After adjust-
ing for the other risk factors, insulin, ALT, HDL choles-
terol, and blood pressure remained significantly associ-
ated with BMI and waist circumference. This suggests that
risk factors for cardiovascular disease, type 2 diabetes, and
fatty liver disease are independently associated with ex-
cess total and central adiposity in adolescent boys.
Adolescent Girls
In adolescent girls, obesity defined using BMI was asso-
ciated with abnormal values of insulin, HDL choles-
terol, hs-CRP, and blood pressure. Using waist circum-
ference to define obesity yielded significant associations
with only insulin, HDL cholesterol, and hs-CRP. The as-
sociation between waist circumference and HDL choles-
terol was slightly higher than that between BMI and HDL
cholesterol but similar to that for insulin and lower for
hs-CRP. In multivariable analysis, after adjusting for the
other risk factors, insulin, HDL cholesterol, and hs-CRP
levels remained significantly associated with BMI. How-
ever, only insulin remained significantly associated with
waist circumference (OR, 3.7; 95% CI, 1.8-7.7). This sug-
gests that in adolescent girls, total fat was a more signifi-
cant predictor of cardiovascular risk than was central
adiposity.
CLUSTERING OF RISK FACTORS
The Figure shows the prevalence of risk factors by BMI
for adolescent boys and girls. Overweight and obese par-
ticipants were more likely to have risk factors than were
nonoverweight participants, and few obese adolescent
boys or girls were without risk factors. Obese adoles-
cent boys were significantly more likely to have 2 or more
risk factors than were adolescent boys who were not over-
Table 1. Age and Prevalence of Overweight and Obesity














Overweight/obesity prevalence, % 21.0/6.6 15.0/4.4
Waist circumference,





Overweight/obesity prevalence, % 10.0/10.0 9.7/8.3
Abbreviation: BMI, body mass index (calculated as weight in kilograms
divided by height in meters squared).






Insulin, median (IQR), µIU/mL 62.5 (41.7-90.3) 62.5 (48.6-97.2)
Glucose, median (IQR), mg/dL 85 (79-88) 81 (77-85)
HDL cholesterol, median (IQR),
mg/dL
50.2 (46.3-57.9) 57.9 (50.2-65.7)
LDL cholesterol, median (IQR),
mg/dL
84.9 (73.4-104.2) 92.7 (77.2-108.1)
Triglycerides, median (IQR),
mg/dL
70.7 (53.0-97.3) 70.7 (61.9-97.3)
High-sensitivity C-reactive
protein, median (IQR), mg/L
0.4 (0.2-1.0) 0.3 (0.2-1.0)
Alanine aminotransferase,
median (IQR), U/L
18.0 (14.0-22.0) 13.0 (11.0-15.0)
-Glutamyltransferase, median
(IQR), U/L
14.0 (11.0-18.0) 11.0 (9.0-13.0)
Systolic blood pressure,
median (IQR), mm Hg
120.0 (115.0-130.0) 110.0 (110.0-120.0)
Diastolic blood pressure,
median (IQR), mm Hg
70.0 (70.0-80.0) 70.0 (65.0-70.0)
Abbreviations: HDL, high-density lipoprotein; IQR, interquartile range;
LDL, low-density lipoprotein.
SI conversion factors: To convert alanine aminotransferase and
-glutamyltransferase to microkatals per liter, multiply by 0.0167; cholesterol
(HDL and LDL) to millimoles per liter, multiply by 0.0259; glucose to millimoles
per liter, multiply by 0.0555; high-sensitivity C-reactive protein to nanomoles
per liter, multiply by 9.524; insulin to picomoles per liter, multiply by 6.945; and
triglycerides to millimoles per liter, multiply by 0.0113.
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weight (73.5% vs 7.6%; OR, 34.0 [95% CI, 12.6-91.7];
P .001). Obese adolescent girls were also significantly
more likely to have 2 or more risk factors compared with
adolescent girls of normal weight (44.4% vs 5.4%; OR,
14.0 [95% CI, 4.1-47.5]; P .001).
COMMENT
To our knowledge, this study presents the first population-
based findings of the association of chronic disease risk
factors and BMI and waist circumference in a represen-
tative sample of Australian adolescents. A high preva-
lence of risk factors was found in overweight and obese
adolescents. In particular, risk factors for cardiovascu-
lar disease and diabetes were common in adolescent boys
and girls, and the prevalence of abnormal ALT and GGT
values was high in adolescent boys. We found that over-
weight adolescent boys, and not only those who were
obese, had a high prevalence of risk factors. This sug-
gests that a dose response may be in effect in that a rela-
tively modest level of excess adiposity (either central or
total) may place an adolescent at increased risk for car-
diovascular, endocrine, and hepatic morbidity. The preva-
lence of risk factors in adolescents with modest levels of
excess adiposity has implications for the screening and
management of young people. Most adolescents who are
overweight or mildly obese will not seek medical care for
their weight problem. However, primary care physi-
cians should be equipped to provide opportunistic coun-
seling regarding weight management at routine health
visits. Although screening for risk factors would not be
feasible or affordable for most individuals, blood pres-
sure can be easily measured, and biochemical analysis is
indicated for obese adolescents. Identification and man-
agement of risk factors in young people who are over-
weight may improve the long-term sequelae.
Risk factors tend to cluster within individuals, and the
presence of more than 1 risk factor in childhood pre-
sents an increased risk of cardiovascular disease in adult-
hood.29,30 The present results suggest that adolescent boys
are more likely to have multiple risk factors than ado-
lescent girls, particularly if they are overweight or obese.
Of particular concern is the finding that 94.7% of obese
and 79.6% of overweight adolescent boys had at least 1
risk factor. Adolescent boys who were overweight or obese
had a higher prevalence of risk factors than adolescent
girls and, with 1 exception (hs-CRP), the association of
each risk factor with obesity was stronger than for over-
weight. The finding of higher hs-CRP levels in adoles-
cent girls in this study is consistent with the study by Cook
Table 3. Summary of the Associations Between Overweight and Obesity, Measured Using BMI and Waist Circumference,












Insulin Not overweight 28 (13.3) 1 [Reference] Not overweight 36 (15.5) 1 [Reference]
Overweight 23 (37.7) 3.9 (2.0-7.8) Overweight 10 (34.5) 2.9 (1.2-6.7)
Obese 15 (78.9) 24.4 (8.2-72.1) Obese 20 (69.0) 12.1 (6.2-23.5)
Glucose Not overweight 1 (0.5) 1 [Reference] Not overweight 2 (0.9) 1 [Reference]
Overweight 1 (1.6) NA Overweight 0 NA
Obese 0 NA Obese 0 NA
HDL cholesterol Not overweight 11 (5.2) 1 [Reference] Not overweight 13 (5.6) 1 [Reference]
Overweight 15 (24.6) 5.9 (2.2-15.3) Overweight 7 (24.1) 5.4 (1.7-17.4)
Obese 5 (26.3) 6.5 (2.4-17.7) Obese 11 (37.9) 10.3 (3.3-32.3)
LDL cholesterol Not overweight 4 (1.9) 1 [Reference] Not overweight 8 (3.4) 1 [Reference]
Overweight 8 (13.1) 7.8 (2.0-30.0) Overweight 1 (3.4) 1.0 (0.1-10.9)
Obese 1 (5.3) 2.9 (0.2-34.9) Obese 4 (13.8) 4.5 (1.1-18.8)
Triglycerides Not overweight 2 (1.0) 1 [Reference] Not overweight 2 (0.9) 1 [Reference]
Overweight 0 NA Overweight 0 NA
Obese 0 NA Obese 0 NA
hs-CRP Not overweight 6 (2.9) 1 [Reference] Not overweight 8 (3.4) 1 [Reference]
Overweight 8 (13.1) 4.7 (1.2-18.5) Overweight 3 (10.3) 3.0 (0.6-15.6)
Obese 6 (31.6) 16.6 (3.5-79.2) Obese 9 (31.0) 12.7 (5.0-31.9)
Alanine aminotransferase Not overweight 10 (4.8) 1 [Reference] Not overweight 14 (6.0) 1 [Reference]
Overweight 14 (23.0) 6.0 (2.6-13.4) Overweight 7 (24.1) 5.0 (1.7-14.8)
Obese 9 (47.4) 18.0 (7.0-46.3) Obese 12 (41.4) 11.0 (6.6-18.4)
-Glutamyltransferase Not overweight 3 (1.4) 1 [Reference] Not overweight 3 (1.3) 1 [Reference]
Overweight 3 (4.9) 3.6 (0.5-23.3) Overweight 3 (10.3) 8.8 (1.2-66.2)
Obese 4 (21.1) 18.4 (3.3-101.6) Obese 4 (13.8) 12.2 (2.5-59.8)
Blood pressure Not overweight 32 (15.2) 1 [Reference] Not overweight 40 (17.2) 1 [Reference]
Overweight 24 (39.3) 3.6 (1.8-7.4) Overweight 12 (41.4) 3.4 (1.6-7.4)
Obese 8 (42.1) 4.0 (1.2-13.3) Obese 12 (41.4) 3.4 (1.4-8.3)
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CI, confidence interval; HDL, high-density
lipoprotein; hs-CRP, high-sensitivity C-reactive protein; LDL, low-density lipoprotein; NA, results not available owing to cell counts of 0.
aFor boys not overweight, n=210; for overweight boys, n=61; and for obese boys, n=19.
bFor boys not overweight, n=232; for overweight boys, n=29; and for obese boys, n=29.
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et al,31 who reported hs-CRP levels 47% higher in women
compared with men. A possible explanation for the higher
prevalence of the other risk factors in adolescent boys is
that, compared with adolescent girls, adolescent boys may
have more abdominal fat than total fat mass, and ab-
dominal fat is more highly correlated with metabolic risk
factors than is total fat.32 The prevalence of obesity in ado-
lescent boys in this study was greater if waist circumfer-
ence was used as the definition, but substantially fewer
adolescent boys would be categorized as overweight by
this definition. It is not clear, therefore, if central adi-
posity is a major determinant in these findings.
The choice of biomarker cut points to determine risk
in adolescents is difficult because the time between risk
factor identification and the development of overt symp-
Table 4. Summary of the Associations Between Overweight and Obesity, Measured Using BMI and Waist Circumference,





No. (%) OR (95% CI) Category
Risk Factor Positive,
No. (%) OR (95% CI)
Insulin Not overweight 26 (15.7) 1 [Reference] Not overweight 27 (16.0) 1 [Reference]
Overweight 15 (48.4) 5.0 (1.8-14.2) Overweight 9 (45.0) 4.3 (1.7-10.8)
Obese 5 (55.6) 6.7 (1.5-29.4) Obese 10 (58.8) 7.5 (3.1-17.8)
Glucose Not overweight 0 1 [Reference] Not overweight 0 1 [Reference]
Overweight 0 NA Overweight 0 NA
Obese 0 NA Obese 0 NA
HDL cholesterol Not overweight 4 (2.4) 1 [Reference] Not overweight 4 (2.4) 1 [Reference]
Overweight 2 (6.5) 2.8 (0.7-10.9) Overweight 1 (5.0) 2.2 (0.5-9.3)
Obese 2 (22.2) 11.6 (3.2-41.4) Obese 3 (17.6) 8.8 (2.5-31.0)
LDL cholesterol Not overweight 9 (5.4) 1 [Reference] Not overweight 10 (6.0) 1 [Reference]
Overweight 3 (9.7) 1.9 (0.5-7.1) Overweight 2 (10.0) 1.8 (0.4-7.9)
Obese 1 (11.1) 2.2 (0.4-11.5) Obese 1 (5.9) 1.0 (0.1-6.9)
Triglycerides Not overweight 0 1 [Reference] Not overweight 0 1 [Reference]
Overweight 0 NA Overweight 0 NA
Obese 1 (11.1) NA Obese 1 (5.9) NA
hs-CRP Not overweight 7 (4.2) 1 [Reference] Not overweight 9 (5.3) 1 [Reference]
Overweight 7 (22.6) 6.8 (2.4-19.0) Overweight 3 (15.0) 3.2 (1.1-9.4)
Obese 2 (22.2) 6.8 (1.7-27.3) Obese 4 (23.5) 5.3 (0.8-12.1)
Alanine aminotransferase Not overweight 1 (0.6) 1 [Reference] Not overweight 2 (1.2) 1 [Reference]
Overweight 2 (6.5) 11.4 (1.0-129.8) Overweight 0 NA
Obese 0 NA Obese 1 (5.9) 5.2 (0.4-63.7)
-Glutamyltransferase Not overweight 3 (1.8) 1 [Reference] Not overweight 4 (2.4) 1 [Reference]
Overweight 2 (6.5) 3.7 (1.0-14.4) Overweight 0 NA
Obese 0 NA Obese 1 (5.9) 2.6 (0.4-15.3)
Blood pressure Not overweight 14 (8.4) 1 [Reference] Not overweight 15 (8.9) 1 [Reference]
Overweight 5 (16.1) 2.1 (0.8-5.4) Overweight 3 (15.0) 1.8 (0.5-6.0)
Obese 3 (33.3) 5.4 (1.7-16.9) Obese 4 (23.5) 3.1 (0.8-12.1)
Abbreviations: See Table 3.
aFor girls not overweight, n=166; for overweight girls, n=31; and for obese girls, n=9.
bFor girls not overweight, n=169; for overweight girls, n=20; and for obese girls, n=17.
Table 5. Multivariable Associations Between Biomarkers
and BMI and Waist Circumference in Adolescent Boys
Variable
Odds Ratio (95% CI)
BMI Waist Circumference
Insulin 4.3 (2.1-8.8) 3.5 (1.8-6.9)
ALT 7.1 (2.9-17.3) 7.0 (2.3-21.2)
HDL cholesterol 5.1 (1.8-14.7) 10.0 (2.3-43.5)
Blood pressure 3.4 (1.8-6.3) 2.9 (1.4-5.9)
Abbreviations: ALT, alanine aminotransferase; BMI, body mass index
(calculated as weight in kilograms divided by height in meters squared);






























Figure. Proportion of adolescent boys (A) and girls (B) in each body mass
index category with different numbers of risk factors.
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toms of disease is not clear. Several studies2,15,33,34 have,
however, provided evidence that risk factors tend to track
into adulthood, where the relationship between risk fac-
tors and overt disease is better understood. The cut points
used in the present study, although somewhat arbitrary,
were chosen after a review of the literature and, where
possible, were based on evidence-based recommenda-
tions or guidelines. Evidence-based recommendations
were chosen for the interpretation of glucose, choles-
terol, triglycerides, hs-CRP, and blood pressure values.
The choice of cut points for the 2 liver enzymes, ALT and
GGT, was based on adult recommendations.21,22 Guide-
lines do not exist for determining elevated insulin lev-
els, but for the present study they were defined as being
at the 75th percentile or higher for adolescent boys and
girls because several large, peer-reviewed, population stud-
ies17,35 had also used that definition. The corresponding
values were similar for the present study and those re-
ported from the Bogalusa Heart Study21,22,35 and the Que-
bec Family Study.17 This cut point is indicative only of
elevated insulin levels and is a surrogate for insulin re-
sistance; it does not provide information on the preva-
lence of insulin resistance in the study population.
The interpretation of cardiovascular risk factors and the
choice of cut points would have been enhanced in the pres-
ent study if questions regarding family history of cardio-
vascular disease could have been included.19 Inclusion of
family history questions was outside the scope of the pres-
ent study and was restricted by ethical constraints.
Similarly, reporting of the consumption of alcohol and
other drugs would have enhanced interpretation of liver
enzyme levels, as would testing for evidence of previous
and current hepatitis B or C infection and other potential
causes of chronic liver disease. The addition of drug and
alcohol questions and further testing of the blood samples
was not possible in the present study. However, the high
prevalence of elevated ALT levels (the most sensitive bio-
chemical marker for nonalcoholic fatty liver disease7) in
overweight (23.7%) and obese (47.3%) adolescent boys,
and the strong association of elevated ALT levels with BMI
and waist circumference, suggests that nonalcoholic fatty
liver disease was present in some adolescents in this study.
The difference in prevalence of elevated ALT levels be-
tween adolescent boys and girls in the present study is con-
sistent with the findings of Schwimmer et al36 that boys
had a 6-fold greater risk of fatty liver disease than did girls.
Another study37 of obese 12-year-old subjects in a clinic
setting found that elevated ALT and BMI values were sig-
nificantly associated with fatty liver disease on ultraso-
nography. Furthermore, a study20 of adults in whom high
alcohol consumption was identified and hepatitis viro-
logic analysis was performed reported that elevated ALT
concentration was unexplained (but significantly associ-
ated with BMI and waist circumference) in 69% of pa-
tients, suggesting that nonalcoholic fatty liver disease is a
relatively common condition. Although alcohol consump-
tion cannot be excluded in this sample of 15-year-old ado-
lescents, it seems unlikely that consumption would be as
prevalent as in a sample of adults and would be signifi-
cantly associated with BMI and central fat distribution.
Many of the long-term sequelae of obesity in adoles-
cents have been identified by well-established, longitu-
dinal cohort studies.9,38 However, the initial recruit-
ment in those studies was undertaken in the 1970s, when
the prevalence of obesity was much lower. Further-
more, none of those studies has as yet examined the natu-
ral history of elevated ALT levels in young people, al-
though this is a relatively common comorbidity of
overweight and obesity in adults. If the adult sequelae
of fatty liver disease were applied to adolescents, seri-
ously compromised liver function and cirrhosis may be
experienced at a relatively young age.
This study reports the prevalence of a range of obesity-
associated morbidities in a representative sample of ado-
lescents. We found that risk factors for cardiovascular
disease, type 2 diabetes, and fatty liver disease are pres-
ent in many overweight and obese adolescent boys. Obese
adolescent girls also have a higher prevalence of risk fac-
tors, but they do not seem to be as adversely affected as
adolescent boys in this sample. The propensity of adi-
posity, behaviors, and risk factors to track from adoles-
cence through adulthood would suggest that health care
systems can expect a greater burden of disease from obe-
sity-related conditions when today’s young people achieve
adulthood.
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